{"favorite_id": 10101, "calc_type": "calculator", "dosing": false, "full_title_en": "TNM Staging for Breast Cancer (8th Edition)", "short_title_en": "TNM Breast CA Staging (8th Ed.)", "medium_description_en": "Stages breast cancer based on tumor, lymph nodes, and metastases (recommended as of 2017).", "short_description_en": "Breast CA staging, recommended as of 2017.", "before_use": "", "instructions_en": "", "purpose_en": ["Prognosis", "Diagnosis"], "disease_en": ["Breast Cancer", "Chemotherapy", "Cancer"], "specialty_en": ["Hematology and Oncology", "OB-Gyn", "Surgery (General)"], "chief_complaint_en": ["Mass", "Cancer"], "system_en": ["Oncologic", "Endocrine and Metabolic"], "search_abbreviation_en": ["tnm", "breast", "ca", "cancer", "lump", "brca"], "slug": "tnm-staging-breast-cancer-8th-edition", "seo": {"meta_description_en": "The TNM Staging for Breast Cancer (2017) stages breast cancer based on tumor, lymph node, and metastasis characteristics.", "keywords_en": "8 edition, 8th edition, tnm, breast ca, breast cancer, ductal breast CA, situ, lobular breast ca, breast tumor, breast lymph, breast mets, breast metastasis"}, "content": {"how_to_use": {"use_case_en": "<p>Patients with breast cancer who have had biopsy.</p>", "pearls_pitfalls_en": "<ul>\n<li>The tumor node metastasis (TNM) system stages breast cancer&nbsp;and prognosticates outcome of patients.</li>\n<li>The staging system is frequently updated in response to new technologies and treatments.</li>\n</ul>", "why_use_en": "<p>The TNM system is the standard staging system used by oncologists to both prognosticate and communicate clearly about patients.</p>"}, "next_steps": {"advice_en": "<p>Use the TNM system once breast cancer diagnosis is biopsy confirmed.</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p><span id=\"docs-internal-guid-464bfa4d-7fff-f05b-99ec-34827a2529af\">Refer to tables in <a href=\"https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC%20Breast%20Cancer%20Staging%20System.pdf#page=38\" target=\"_blank\">AJCC Staging Manual 2017, pg 38-39</a>.</span></p>", "more_info_en": "<p><span id=\"docs-internal-guid-ffda26e3-7fff-3143-bc0c-21540640c9c6\">Refer to tables in <a href=\"https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC%20Breast%20Cancer%20Staging%20System.pdf#page=40\" target=\"_blank\">AJCC Staging Manual 2017, pg 40-46</a>.</span></p>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC%20Breast%20Cancer%20Staging%20System.pdf", "text": "American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017."}], "Other References": [{"href": "", "text": ""}], "Validation": [{"href": "", "text": ""}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "reviewer": {"expert_name": []}, "creator": [{"name": "Dr. Armando Giuliano", "creator_info": {"about_en": "Armando Giuliano, MD, is a clinician and investigator appointed as the Linda and Jim Lippman Chair in surgical oncology. He is also co-director of the Saul and Joyce Brandyman Breast Center at Cedars-Sinai Medical Center. Dr. Giuliano\u2019s primary research is focused on treatment of breast cancer.", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-armando-giuliano.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Giuliano+A%5Bau%5D%EF%BB%BF"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Primary tumor (T)", "name": "T", "options": [{"label": "Primary tumor cannot be assessed (TX)", "value": 1}, {"label": "No evidence of primary tumor (T0)", "value": 2}, {"label": "Ductal carcinoma in situ (Tis (DCIS))", "value": 3}, {"label": "Paget disease of the nipple NOT associated with invasive carcinoma and/or carcinoma in situ (DCIS) in the underlying breast parenchyma (Tis (Paget))", "value": 4}, {"label": "Tumor \u226420 mm in greatest dimension (T1)", "value": 5}, {"label": "Tumor >20-50 mm in greatest dimension (T2)", "value": 6}, {"label": "Tumor >50 mm in greatest dimension (T3)", "value": 7}, {"label": "Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify (T4)", "value": 8}], "conditionality": "", "show_points": false, "default": 1, "optional": false}, {"type": "radio", "label_en": "T1", "name": "T1", "options": [{"label": "Tumor \u22641 mm in greatest dimension (T1mi)", "value": 1}, {"label": "Tumor >1-5 mm in greatest dimension (round any measurement >1.0\u20131.9 mm to 2 mm) (T1a)", "value": 2}, {"label": "Tumor >5-10 mm in greatest dimension (T1b)", "value": 3}, {"label": "Tumor >10-20 mm in greatest dimension (T1c)", "value": 4}], "conditionality": "T == 5", "show_points": false, "optional": false}, {"type": "radio", "label_en": "T4", "name": "T4", "options": [{"label": "Extension to the chest wall; invasion or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify (T4a)", "value": 1}, {"label": "Ulceration and/or ipsilateral macroscopic satellite nodules and/or edema (including peau d\u2019orange) of the skin that does not meet the criteria for inflammatory carcinoma (T4b)", "value": 2}, {"label": "Both T4a and T4b are present (T4c)", "value": 3}, {"label": "Inflammatory carcinoma (T4d)", "value": 4}], "conditionality": "T == 8", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Regional lymph nodes - clinical (cN)", "name": "cN", "options": [{"label": "Regional lymph nodes cannot be assessed (e.g. previously removed) (cNX)", "value": 1}, {"label": "No regional lymph node metastases (by imaging or clinical examination) (cN0)", "value": 2}, {"label": "Metastases to movable ipsilateral Level I, II axillary lymph node(s) (cN1)", "value": 3}, {"label": "Metastases in ipsilateral Level I, II axillary lymph nodes that are clinically fixed or matted; or in ipsilateral internal mammary nodes in the absence of axillary lymph node metastases (cN2)", "value": 4}, {"label": "Metastases in ipsilateral infraclavicular (Level III axillary) lymph node(s) with or without Level I, II axillary lymph node involvement; or in ipsilateral internal mammary lymph node(s) with Level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement (cN3)", "value": 5}], "conditionality": "", "show_points": false, "default": 1, "optional": false}, {"type": "toggle", "label_en": "Micrometastases", "name": "cN1mi", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "conditionality": "cN == 3", "show_points": false, "tips_en": "Approximately 200 cells, >0.2-2.0 mm", "optional": false}, {"type": "radio", "label_en": "cN2", "name": "cN2", "options": [{"label": "Metastases in ipsilateral Level I, II axillary lymph nodes fixed to one another (matted) or to other structures (cN2a)", "value": 1}, {"label": "Metastases only in ipsilateral internal mammary nodes in the absence of axillary lymph node metastases (cN2b)", "value": 2}], "conditionality": "cN == 4", "show_points": false, "optional": false}, {"type": "radio", "label_en": "cN3", "name": "cN3", "options": [{"label": "Metastases in ipsilateral infraclavicular lymph node(s) (cN3a)", "value": 1}, {"label": "Metastases in ipsilateral internal mammary lymph node(s) and axillary lymph node(s) (cN3b)", "value": 2}, {"label": "Metastases in ipsilateral supraclavicular lymph node(s) (cN3c)", "value": 3}], "conditionality": "cN == 5", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Regional lymph nodes - pathologic (pN)", "name": "pN", "options": [{"label": "Regional lymph nodes cannot be assessed (e.g. not removed for pathological study or previously removed) (pNX)", "value": 1}, {"label": "No regional lymph node metastasis identifed or <abbr title = \"Isolated tumor cells\">ITCs</abbr> only (pN0)", "value": 2}, {"label": "Micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy (pN1)", "value": 3}, {"label": "Metastases in 4-9 axillary lymph nodes or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases (pN2)", "value": 4}, {"label": "Metastases in \u226510 axillary lymph nodes; OR in infraclavicular (Level III axillary) lymph nodes; OR positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive Level I, II axillary lymph nodes; OR in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; OR in ipsilateral supraclavicular lymph nodes (pN3)", "value": 5}], "conditionality": "", "show_points": false, "default": 1, "optional": false}, {"type": "radio", "label_en": "pN0", "name": "pN0", "options": [{"label": "<abbr title = \"Isolated tumor cells\">ITCs</abbr> only (malignant cell clusters \u22640.2 mm) in regional lymph node(s) (pN0(i+))", "value": 1}, {"label": "Positive molecular findings by reverse transcriptase polymerase chain reaction (RT-PCR); no <abbr title = \"Isolated tumor cells\">ITCs</abbr> detected (pN0(mol+))", "value": 2}], "conditionality": "pN == 2", "show_points": false, "optional": false}, {"type": "radio", "label_en": "pN1", "name": "pN1", "options": [{"label": "Micrometastases (approximately 200 cells, >0.2-2.0 mm) (pN1mi)", "value": 1}, {"label": "Metastases in 1-3 axillary lymph nodes, at least one metastasis >2.0 mm (pN1a)", "value": 2}, {"label": "Metastases in ipsilateral internal mammary sentinel nodes, excluding <abbr title = \"Isolated tumor cells\">ITCs</abbr> (pN1b)", "value": 3}, {"label": "pN1a and pN1b combined (pN1c)", "value": 4}], "conditionality": "pN == 3", "show_points": false, "optional": false}, {"type": "radio", "label_en": "pN2", "name": "pN2", "options": [{"label": "Metastases in 4-9 axillary lymph nodes (at least one tumor deposit >2.0 mm) (pN2a)", "value": 1}, {"label": "Metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary nodes (pN2b)", "value": 2}], "conditionality": "pN == 4", "show_points": false, "optional": false}, {"type": "radio", "label_en": "pN3", "name": "pN3", "options": [{"label": "Metastases in \u226510 axillary lymph nodes (at least one tumor deposit >2.0 mm); OR metastases to the infraclavicular (Level III axillary lymph) nodes (pN3a)", "value": 1}, {"label": "pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); OR pN2a in the presence of pN1b (pN3b)", "value": 2}, {"label": "Metastases in ipsilateral supraclavicular lymph nodes (pN3c)", "value": 3}], "conditionality": "pN == 5", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Distant metastasis - clinical (cM)", "name": "M", "options": [{"label": "No clinical or radiographic evidence of distant metastases in the presence of tumor cells or deposits \u22640.2 mm detected microscopically or by molecular techniques in circulating blood, bone marrow, or other nonregional nodal tissue in a patient without symptoms or signs of metastases (cM0(i+))", "value": 1}, {"label": "Distant metastases detected by clinical and radiographic mean (cM1)", "value": 2}], "conditionality": "", "show_points": false, "default": 0, "optional": false}, {"type": "radio", "label_en": "Distant metastasis - pathologic (pM)", "name": "pM", "options": [{"label": "No clinical or radiographic evidence of distant metastases (M0)", "value": 1}, {"label": "Any histologically proven metastases in distant organs; or if in non-regional nodes, metastases >0.2 mm (pM1)", "value": 3}], "conditionality": "", "show_points": false, "default": 0, "optional": false}, {"type": "radio", "label_en": "Tumor grade", "name": "G", "options": [{"label": "G1", "value": 1}, {"label": "G2", "value": 2}, {"label": "G3", "value": 3}], "conditionality": "", "show_points": false, "default": 0, "optional": false}, {"type": "radio", "label_en": "<abbr title = \"Human epidermal growth factor receptor 2\">HER2</abbr> status", "name": "her2", "options": [{"label": "Negative", "value": 0}, {"label": "Positive", "value": 1}], "conditionality": "", "show_points": false, "default": 0, "optional": false}, {"type": "radio", "label_en": "<abbr title = \"Estrogen receptor\">ER</abbr> status", "name": "er", "options": [{"label": "Negative", "value": 0}, {"label": "Positive", "value": 1}], "conditionality": "", "show_points": false, "default": 0, "optional": false}, {"type": "radio", "label_en": "<abbr title = \"Progesterone receptor\">PR</abbr> status", "name": "pr", "options": [{"label": "Negative", "value": 0}, {"label": "Positive", "value": 1}], "conditionality": "", "show_points": false, "default": 0, "optional": false}, {"type": "radio", "label_en": "Genomic profiling score", "name": "gen", "options": [{"label": "Not done", "value": -1}, {"label": "<11", "value": 0}, {"label": "\u226511", "value": 1}], "conditionality": "(T==5 && M==1 && pN == 2) || (T==6 && M==1 && pN == 2)", "show_points": false, "default": 0, "optional": false}], "md5": "dfd0de9932beb37289721b608e0b0a3f", "related_calcs": [{"calcId": 2170, "short_title_en": "TNM Breast CA Staging", "slug": "tnm-staging-breast-cancer"}, {"calcId": 10178, "short_title_en": "TNM Pancreatic CA Staging (8th Ed.)", "slug": "tnm-staging-pancreatic-cancer-8th-edition"}, {"calcId": 3314, "short_title_en": "TNM Pancreatic CA Staging", "slug": "tnm-staging-pancreatic-cancer"}]}